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Abstract
Rainbow trout are carnivorous fish and poor metabolizers of carbohydrates, which established this species as a model
organism to study the comparative physiology of insulin. Following the recent characterisation of key roles of several
miRNAs in the insulin action on hepatic intermediary metabolism in mammalian models, we investigated the hypothesis
that hepatic miRNA expression is postprandially regulated in the rainbow trout and temporally coordinated in the context
of insulin-mediated regulation of metabolic gene expression in the liver. To address this hypothesis, we used a time-course
experiment in which rainbow trout were fed a commercial diet after short-term fasting. We investigated hepatic miRNA
expression, activation of the insulin pathway, and insulin regulated metabolic target genes at several time points. Several
miRNAs which negatively regulate hepatic insulin signaling in mammalian model organisms were transiently increased 4 h
after the meal, consistent with a potential role in acute postprandial negative feed-back regulation of the insulin pathway
and attenuation of gluconeogenic gene expression. We equally observed a transient increase in omy- miRNA-33 and omy-
miRNA-122b 4 h after feeding, whose homologues have potent lipogenic roles in the liver of mammalian model systems. A
concurrent increase in the activity of the hepatic insulin signaling pathway and the expression of lipogenic genes (srebp1c,
fas, acly) was equally observed, while lipolytic gene expression (cpt1a and cpt1b) decreased significantly 4 h after the meal.
This suggests lipogenic roles of omy-miRNA-33 and omy-miRNA-122b may be conserved between rainbow trout and
mammals and that these miRNAs may furthermore contribute to acute postprandial regulation of de novo hepatic lipid
synthesis in rainbow trout. These findings provide a framework for future research of miRNA regulation of hepatic
metabolism in trout and will help to further elucidate the metabolic phenotype of rainbow trout.
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Introduction
Maintenance of energy homeostasis in intermediary metabolism
in vertebrates is critically regulated by insulin, which exerts actions
on glucose and lipid metabolism in the liver [1]. Generally, insulin
exerts anabolic effects with respect to these pathways, with a
stimulatory effect on glycolysis and fatty acid synthesis, and a
concurrent inhibition of gluconeogenesis and fatty acid oxidation
[1]. Insulin exerts further anabolic effects at the level of protein
metabolism, by stimulating protein synthesis and inhibiting
autophagy [1,2]. In pathological states, such as type-II diabetes,
insulin signaling is impaired in liver cells, resulting in aberrant
regulation of glucose and lipid metabolism [3]. This is character-
ized by an absence of inhibition on gluconeogenesis and fatty acid
oxidation, resulting in development of hyperglycemia and
hypertriglycemia [4].
In recent mammalian literature [5,6,7], an involvement of
miRNAs in the aetiology of insulin resistance in type-II diabetes
has been hypothesized through the identification of altered hepatic
expression of miRNAs in animal models of obesity and insulin-
resistance. miRNAs are a family of short transcribed non-coding
nucleotide sequences (,21 nt), which are exported from the
nucleus to bind to the mRNAs of target genes by complementary
base-pairing mediated by the seed region of the miRNA [8]. The
binding between miRNA and its specific mRNA target(s) results in
the formation of a RISC (RNA-induced silencing complex), which,
depending on the amount of complementarity of base pairing,
causes degradation of the target mRNA or inhibition of its
translation, respectively [8]. The identification of particular
miRNAs as potential regulators of hepatic metabolism in
mammals was followed by the demonstration of direct physiolog-
ical functions of these individual mammalian miRNAs on
components of the hepatic insulin pathway, which can be divided
into several nodes [9], as depicted in Fig. 1. Briefly, insulin acts to
recruit IRS proteins (node 1), which in turn recruit PI3K (node 2)
to phosphorylate Akt (node 3). Downstream of Akt, the insulin
pathway is bifurcated [10], and subsequent metabolic effects are to
a large extent mediated by mTOR and FoxO1. The mTOR
pathway subsequently regulates S6K1 and 4-EBP1 to stimulate
hepatic protein synthesis and, at least partially, is involved in the
stimulation of lipogenesis by stimulating SREBP1C-dependent
gene expression [10,11]. The FoxO1 pathway is primarily known
to mediate insulin dependent repression of hepatic gluconeogen-
esis, at the level of gene expression [12]. Both, phosphorylation of
mTOR and FoxO1 have been shown to inhibit hepatic autophagy
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glucose [15], and lipid [16] homeostasis in mammals.
Several miRNAs can modulate protein abundance and/or
phosphorylation status of key signaling components of the hepatic
insulin pathway by acting at the level of different nodes. At the
level of node 1 for example, hsa-miRNA-126, hsa-miRNA-33a, hsa-
miRNA-33b act by inhibiting hepatic IRS1 and IRS2 protein
abundance in vivo and in vitro [17,18,19]. At the level of node 3,
mmu-hsa-miRNA-29, mmu-miRNA-103, mmu-miRNA-107, mmu-
miRNA-143 have been shown to inhibit Akt phosphorylation
status in vivo and in vitro [20,21,22]. Conversely, hsa-miRNA-21 and
hsa-miRNA-22 are known to target PTEN, a negative regulator of
Akt phosphorylation status [23,24] and over-expression of hsa-
miRNA-21 and hsa-miRNA-22 has consequently been linked to
increased insulin-stimulated Akt phosphorylation in the liver in
vitro [23,24]. Downstream of the third node, liver specific mmu-
miRNA-122 [25], as well as mmu-miRNA-33 [18,26] have been
shown to be inversely correlated with the gene expression and/or
phosphorylation status of the a-subunit of the metabolic sensor
AMPK. Overall, the functions of the described miRNAs (Fig. 1)
are consistent with postulated roles of miRNAs as feedback
regulators, implicated in ‘fine-tuning’ regulation of target path-
ways [27]. Indeed, the insulin pathway in mammals has been
predicted as a target pathway for miRNA mediated feedback [28].
In addition to regulating components of the insulin pathways,
miRNAs can also directly act on downstream genes important in
metabolism (Table 1), resulting in a complex regulatory network.
Physiologically, the described miRNA-mediated inhibitions of
components of the insulin signaling pathway result in measurable
metabolic effects in mammalian model systems. Based on these
metabolic effects, the described miRNAs can be functionally
divided into two groups, acting primarily on glucose metabolism
(Fig. 1, left handside) and lipid metabolism (Fig. 1, right
handside). With respect to glucose metabolism, for example, hsa-
miRNA-29, hsa-miRNA-126, mmu-microRNA-103/107 generally fa-
vour hepatic glucose liberation, by inhibiting hepatic glucose
storage [17] or favouring hepatic gluconeogenesis, at least partially
by counteracting insulin-mediated repression of gluconeogenic
genes g6pase, pepck and fbpase in the liver [20,21]. Hepatic lipid
metabolism is functionally regulated by mmu-miRNA-33 and mmu-
miRNA-122 in vivo and in vitro, which favour lipogenesis through
stimulating hepatic gene expression of srebp1, acly and fas while
concurrently inhibiting fatty acid oxidation at least partially
through the inhibition of cpt1a gene expression [18,19,25,29]. As
miRNAs act to inhibit target gene abundance or translation, the
positive correlation between the expression of these miRNAs and
the lipogenic target genes was speculated to be caused by targeting
AMPK, an upstream repressor normally repressing the lipogenic
pathway at the level of mTOR under low energy conditions
[18,25].
Based on these findings, we hypothesized that the hepatic
expression of corresponding omy-miRNA homologues are acutely
regulated in the postprandial regulation of intermediary metab-
olism in the liver of rainbow trout (Oncorhynchus mykiss). Rainbow
trout emerged as an important model organism in the investiga-
Figure 1. Schematic representation of experimentally validated actions of mammalian miRNAs on the mammalian hepatic insulin
signaling pathway. Encircled + or – symbols indicate a stimulatory and inhibitory role on the insulin pathway in mammalian model systems. See
text for explanations.
doi:10.1371/journal.pone.0038604.g001
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[32] makes the trout an important model for pathologies such as
type II diabetes, characterized by prominent glucose intolerance
[3]. Furthermore, its importance as an aquaculture species [33]
has led to detailed investigations of the insulin pathway in trout, in
order to understand the effect of nutrient composition on the
insulin pathway and its subsequent regulation of intermediary
metabolism [38]. Generally, insulin action in the liver of rainbow
trout appears to be largely similar to mammals, inhibiting
catabolic reactions while stimulating anabolic processes. Insulin
activates key components of the hepatic intracellular signaling in
vitro and in vivo [34,35] resulting in metabolic effects mediated at
the level of hepatic gene expression similar to the situation in
mammals. For example, insulin inhibits gluconeogenic gene
expression, decreases gluconeogenic enzyme activity [36,37] and
stimulates lipogenesis by the acute stimulation of lipogenic gene
expression in vitro and in vivo [31,37,38]. Therefore, the importance
of rainbow trout as a research model for insulin action with its
detailed characterization of hepatic insulin signaling and function,
as well as the recent identification of omy-miRNAs [33], make this
species suitable to investigate the postprandial regulation of
hepatic omy-miRNA in relation to insulin signaling and target
genes.
[LOSSEST]Specifically, we first chose conserved omy-miRNAs
based on the function of their human homologues on the insulin
pathway and approximated the conservation of predicted targets
through genome-based predictions for miRNA homologues in
several fish species (Table 1). We then refed short-term fasted
rainbow trout and measured the postprandial hepatic expression
profile of omy-miRNAs (Table 2), the phospohorylation status of
key signaling components of the insulin pathway (Akt, mTOR, S6,
4-EBP1, FoxO1) and metabolic gene targets, including genes
involved in glucose metabolism (pepck, g6pase1, g6pase2, fbpase2)
lipid metabolism (srebp1c, fas, acly, gapdh, cpt1a, cpt1b), and
autophagy (atg4b, lc3b). This experimental design allows for a
temporal resolution of multiple levels of control regulating the
hepatic intermediary metabolism in trout.
Materials and Methods
Prediction of MiRNA Target Genes in Fish
The target miRNAs investigated in this study were chosen based
on their described effects on the mammalian insulin pathway in
the liver. However, miRNAs can equally target downstream
regulated genes of the insulin pathway directly. In order to predict
the potential for omy-miRNAs to regulate both, components of the
hepatic insulin pathway, as well as metabolic genes in trout, the
Table 1. Predicted target genes of fish homologues of human miRNAs known to act on the hepatic insulin pathway.
Target gene hsa-miRNA gac-miRNA ola-miRNA dre-miRNA tru-miRNA tni-miRNA
Insulin signalling
irs1 126 none none 22,29 none none
irs2 none 29,103,107 103,107 none none 21
pi3k class1
(various subunits)
103,107,143 21,22,33,103,107,126 21,33,126 none 21,29,33,143 29,107,143
Pten none 103,107 103,107,143 none none none
mTOR none none none none none none
s6k
(various subunits)
22,29,103,107 22,29,33,122 22,29,103,107,122 21,143 21,22,29,33,122 29,33,122
S6 none none 126 none none none
4-ebp1 none none none none none none
foxO1 none 21 21 none none none
Glucose metabolism
m-pepck 33 none 21,33 none 22 33
g6pase 21,122 33 33 none 143 143
fbpase2 22,33 none 103,107 none 107 none
Lipid metabolism
srebp1 none none none none none none
Fas 103,107 122 none none 122 none
Acly 103,107 103,107 103,107 none none none
Gapdh 122 29,33 none none none 143
cpt1a 33 none none 103,107 none none
cpt1b 103,107 none none none none none
Autophagy
lc3b none none none none none none
atg4b none 29 none none none 29
The in silico prediction algorithms of miRNA targets available for fish included Japanese medaka (Oryzias latipes), the stickleback (Gasterosteus aculeatus), the Fugu
pufferfish (Takifugu rubripes), the green-spotted pufferfish (Tetraodon nigroviridis) and zebrafish (Danio rerio) and were used in addition to human (Homo sapiens)
predictions as an approximation for omy-miRNA targets. All predictions are derived from the microCosm database.
doi:10.1371/journal.pone.0038604.t001
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microcosm/htdocs/targets/v5/) was used. The in silico prediction
algorithms of miRNA targets available for fish species do not
include rainbow trout, but include predictions for the stickleback
(Gasterosteus aculeatus), the Japanese medaka (Oryzias latipes), the
zebrafish (Danio rerio) and two puffer fish species (Takifugu rubripes
and Tetraodon nigroviridis). Therefore, predictions for miRNA
targets in these fish species were used in addition to human (Homo
sapiens) predictions to serve as an approximation for potential
target conservation in rainbow trout (Table 1).
Fish and Experimental Protocol
The experiments were carried out in accordance with the clear
boundaries of EU legal frameworks, specifically those relating to
the protection of animals used for scientific purposes (i.e. Directive
2010/63/EU), and under the French legislation governing the
ethical treatment of animals (Decret no. 2001-464, May 29
th,
2001). The investigators carrying out the experiment had ‘‘level 1’’
or ‘‘level 2’’ certification, bestowed by the Direction De ´parte-
mentale des Services Ve ´te ´rinaires (French vetinary services) to
carry out animal experiments (INRA 2002-36, April 14
th, 2002).
The experiment was conducted at INRA St.Pe ´e-sur-Nivelle,
certified for animal services under the permit number A64.495.1
by the French vetinary services, which is the competent authority.
Prior to the experiment, fish had initially been reared in our own
experimental facilities (INRA, Donzacq, France) at 18uC and fed a
commercial diet (Skretting, France; crude protein: 49.8% dry
matter, crude fat: 13.8% dry matter; gross energy: 22 kJ/g dry
matter). Immediately prior to the experiment, fish were fasted for
48 h, in order to allow for basal metabolite plasma concentrations
to be reached. In trout, these basal metabolite concentrations are
typically reached more slowly compared to endothermic mammals
due to slower intestinal transit and gastric emptying. Following the
fast, fish were fed once at libitum with the commercial diet. Six
trout were sampled for each time point, starting with unfed fish at
0 h, and following feeding at 2 h, 4 h, 8 h, 12 h, 16 h and 24 h.
Immediately following complete anaesthesia, which was confirmed
by a complete absence of breathing or swimming response, trout
were killed by a sharp blow to the head and decapitated to ensure
fish were dead. Gut content of the sampled animals was checked to
verify that fish had effectively consumed the diet. Blood was taken
from the caudal vein and centrifuged (3000 g, 5 min) and the
plasma recovered was immediately stored at 220uC. The liver was
dissected and frozen in liquid nitrogen prior to storage at 280uC.
Relative Gene Expression Analysis of Hepatic MiRNA and
MRNA
Relative hepatic gene expression was determined by quantita-
tive real-time RT-PCR. The extraction of total RNA was
performed using the Trizol reagent (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s instructions. An amount of
1 mg of total RNA was used for cDNA synthesis. The NCode
TM
VILO
TM miRNA cDNA synthesis kit (Invitrogen) or the
SuperScript III RNAseH- Reverse transcriptase kit (Invitrogen)
with oligo dT primers (Promega, Charbonnie ´res, France) was used
to synthesize cDNA (n=6 for each time point) for miRNA and
mRNA, respectively. For gene expression assays, forward primer
sequences for miRNAs were taken directly from the sequence
information provided by Salem and colleagues [33], or, if not
available, designed based on miRNA sequences found in miRBase
[39]. The reverse primer used for all miRNA expression analysis
was provided by the manufacturer with the NCode
TM VILO
TM
miRNA cDNA synthesis kit (Invitrogen). The primer sequences
used in the real-time RT-PCR assays for miRNAs and metabolic
genes are shown in Table 2 and Table 3, respectively. For real-
time RT-PCR assays of omy-miRNAs, the Roche Lightcycler 480
system was used (Roche Diagnostics, Neuilly sur Seine, France).
The assays were performed using a reaction mix of 6 ml per
sample, each of which contained 2 ml of diluted cDNA template,
0.12 ml of each primer (10 mM), 3.12 ml Light Cycler 480 SYBRH
Green I Master mix and 0.76 ml DNAse/RNAse free water (5
Prime GmbH, Hamburg, Germany). The PCR protocol was
initiated at 95uC for 10 min for initial denaturation of the cDNA
and hot-start Taq-polymerase activation, followed by 45 cycles of
a two-step amplification programme (15 s at 95uC; 40 s at 60–
64uC), according to the primer set used (Table 2). Melting curves
were systematically monitored (temperature gradient at 1.1uC/
10 s from 65–94uC) at the end of the last amplification cycle to
confirm the specificity of the amplification reaction. Each PCR
assay included replicate samples (duplicate of reverse transcription
and PCR amplification, respectively) and negative controls
(reverse transcriptase- and cDNA template-free samples, respec-
tively). The gene expression assays for the metabolic genes has
been described previously [35] and were carried out using the
icycler iQ
TM real-time PCR detection system. Assays were
performed using a reaction mix of 15 ml per sample, each
containing 5 ml of diluted cDNA, 0.5 ml of each primer (10 mM),
7.5 mlo fi Q
TM SYBRH Green Supermix (BIORAD, Hercules,
CA, USA) and 1.9 ml of DNAse/RNAse free water. The PCR
protocol was initiated at 95uC for 3 min for initial denaturation of
the cDNA and hot-start iTaq
TM DNA polymerase activation and
continued with 35 cycles of a two-step amplification programme
(20 s at 95uC; 20 s at 56–60uC), according to the primer set used
(Table 3). Melting curves were systematically monitored (tem-
perature gradient at 0.5uC/10 s from 55–94uC) at the end of the
last amplification cycle to confirm the specificity of the amplifi-
cation reaction. Each PCR run included replicate samples and
controls as described above. For the expression analysis of both,
miRNA and mRNA, relative quantification of target gene
expression was performed using the DCT method described by
Pfaffl [40]. The relative gene expression of ef1a was used for the
normalization of measured mRNAs, and miRNAs, respectively.
The relative expression of ef1a did not significantly change over
time (data not shown). The reference gene ef1a has been previously
used as a reference gene for analysis of postprandial metabolic
gene expression in trout in vivo [35]. In all cases, PCR efficiency (E)
was measured by the slope of a standard curve using serial
dilutions of cDNA. In all cases, PCR efficiency values ranged
between 1.8 and 2.2.
Table 2. Primers and conditions for miRNA expression assays.
miRNA target Primer 59 39 (FW) T
omy-miRNA-21a TAGCTTATCAGACTGGTGTTGGC 62uC
omy-miRNA-22 TGCCAGCTGAAGAACTGT 60uC
omy-miRNA-29a GCACCATTTGAAATCCAGTGT 62uC
omy-miRNA-33 GTCATTGTAGTTGCATTGA 61uC
omy-miRNA-103 AGCATTGTACAGGGCTATCA 60uC
omy-miRNA-107 AGCATTGTACAGGGCTATGA 64uC
omy-miRNA-122a TGGAGTGTGACAATGGTGTTTT 60uC
omy-miRNA-122b TGGAGTGTGACAATGGTGTCT 60uC
omy-miRNA-126a TCGTACCGTGAGTAATAATGC 61uC
omy-miRNA-143 TGAGATGAAGCACTGTAGCTC 61uC
doi:10.1371/journal.pone.0038604.t002
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Frozen liver samples (,300 mg) were homogenized on ice with
an Ultraturrax homogenizer (IMLAB Sarl, Lille, France). During
homogenization samples were kept in a buffer containing
150 mmol l
21 NaCl, 10 mmol l
21 Tris, 1 mmol l
21 EGTA,
1 mmol l
21 EDTA (pH 7.4), 100 mmol l
21 sodium fluoride,
4 mmol l
21 sodium pyrophosphate, 2 mmol l
21 sodium orthova-
nadate, 1% (v/v) Triton X-100, 0.5% (v/v) NP40-IGEPAL and a
protease inhibitor cocktail (Roche, Basel, Switzerland). Homoge-
nates were centrifuged at 1000 g for 30 min at 4uC and
supernatants were then centrifuged for 45 min at 150.000 g.
The resulting supernatants (n=5 for each time point) were stored
at 280uC. Protein concentrations were determined using the Bio-
Rad Protein assay kit (BIO-RAD, Hercules, CA, USA). According
to the protein, quantities of 5–20 mg protein per sample were
subjected to SDS-PAGE and Western Blotting, using the
appropriate antibodies. All primary antibodies used for analysis
of the insulin signaling pathway were obtained from Cell Signaling
technologies (Ozyme, Saint Quentin Yvelines, France) and have
been shown to cross-react successfully with rainbow trout proteins
of interest [34,41,42]. The specific dilutions used for the primary
antibodies are shown in Table 4. All antibodies were raised in
rabbit, and after final washing, membranes were incubated with
an IRDye infrared secondary anti-rabbit antibody raised in goat
(LI-COR Inc. Biotechnology, Lincoln, NE, USA). Bands were
visualized and quantified by Infrared fluorescence using the
OdysseyH Imaging System (LI-COR Inc. Biotechnology, Lincoln,
NE, USA).
Statistical Analysis
Data were analyzed by univariate ANOVA. In cases where data
were nonparametric or not homoscedastic, data transformations
were used to meet ANOVA criteria. Normality was assessed using
the Shaprio-Wilk test, while equality of variance was determined
using Levene’s test. Following univariate ANOVA analysis, the
Student-Newman-Keuls test was used for post-hoc analysis. Data
was analysed using the SPSS software version 17.0.
Results
Predicted Conservation of Predicted Fish MiRNA Targets
Compared to Humans
With respect to the insulin pathway, several miRNAs appear to
have conserved predicted targets between fish and humans
(Table 1). This is especially evident with regard to the targeting
of PI3K kinase, which across the different fish species is predicted
to be targeted by all miRNAs predicted in humans, including
homologues of miRNA-103, miRNA-107 and miRNA-143.
Table 3. Primers and conditions for mRNA expression assays.
mRNA target Primer 5939 (FW) Primer 5939 (RV) T
Glucose Metabolism
m-pepck GTTGGTGCTAAAAGGGGCACAC CCCGTCTTCTGATAAGTCCAA 59uC
g6pase1 CTCAGTGGCGACAGAAAGG TACACAGCAGCATCCAGAGC 55uC
g6pase2 CAGAAGAACGCCCACAGAGT CAGAAGAACGCCCACAGACT 55uC
fbpase2 GCTGGACCCTTCCATCGG CGACATAACGCCCACCATAGG 59uC
Lipid Metabolism
srebp1c GACAAGGTGGTCCCAGTTGCT CACACGTTAGTCCGCATCAC 60uC
Fas TGATCTGAAGGCCCGTGTCA GGGTGACGTTGCCGTGGTAT 60uC
acly1 GCTTTTGCCACGGTGGTCTC GCTTCCGCTACGCCAATGTC 59uC
g6pdh CTCATGGTCCTCAGGTTTG AGAGAGCATCTGGAGCAAGT 59uC
cpt1a TCGATTTTCAAGGGTCTTCG CACAACGATCAGCAAACTGG 55uC
cpt1b CCCTAAGCAAAAAGGGTCTTCA CATGATGTCACTCCCGACAC 59uC
Autophagy-related genes
lc3b GAACAGTTTGACCTGCGTGAA TCTCTCAATGATGACCGGAATCT 57uC
atg4b TATGCGCTTCCGAAAGTTGTC CAGGATCGTTGGGGTTCTGC 58uC
Reference genes
eF1a TCCTCTTGGTCGTTTCGCTG ACCCGAGGGACATCCTGTG 59uC
doi:10.1371/journal.pone.0038604.t003
Table 4. Primary antibodies and specific dilutions used in
Western Blot analysis.
Protein target Primary AB source Dilution of primary AB
Insulin signaling
Akt-p Cell Signaling 9272 1:1000
Akt Cell Signaling 9271 1:1000
mTOR-p Cell Signaling 2972 1:1000
mTOR Cell Signaling 2971S 1:1000
S6-p Cell signaling 4856S 1:1000
S6 Cell Signaling 2217S 1:1000
4EBPI-p Cell Signaling 9452S 1:1000
4EBP1 Cell Signaling 9451S 1:1000
FoxO1-p Cell Signaling 9464 1:500
FoxO1 Cell Signaling 9454 1:500
doi:10.1371/journal.pone.0038604.t004
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miRNA-126 are predicted to target components of the insulin
pathway upstream of node 3. However, differences in the
predictions between humans and fish and between fish species
exist, which is also evident for other components of the insulin
signaling pathway downstream of the third node. In lipid
metabolism related genes, acly is predicted to be targeted directly
by miRNA-103/107 homologues in both humans and stickleback
and medaka fish species. Of the metabolic genes involved in
glucose metabolism, m-pepck is predicted to be targeted by miRNA-
33 homologues in both humans and medaka and fugu fish species.
Of the genes involved in autophagy, neither lc3b nor atg4 are
predicted to be targeted by the investigated miRNA in humans,
but miRNA-29 homologues are predicted to target lc3b in two fish
species, stickleback and fugu.
Postprandial Regulation of MicroRNAs Involved in
Hepatic Metabolism
Time had a significant effect on the expression of omy-miRNAs
whose mammalian homologues are implicated in the regulation of
the insulin signaling cascade, particularly with respect to the
regulation of glucose metabolism (Fig. 2A–G). The expression of
omy-miRNA-21 (df=6; F=4.54; p,0.01), omy-miRNA-22 (df=6;
F=5.46; p,0.01), omy-miRNA-29a (df=6; F=4.35; p,0.01), omy-
miRNA-103 (df=6; F=8.06; p,0.01), omy-miRNA-107 (df=6;
F=5.59; p,0.01); omy-miRNA-143 (df=6; F=3.79; p,0.05)
exhibited significant postprandial changes. A significant increase
in expression of several of these miRNAs was observed at 4 h after
refeeding when compared to other time points (Fig. 2B–G), the
exceptions being omy-miRNA-103 and to some extent omy-miRNA-
29a and omy-miRNA-107, which exhibited an additional second
increase in expression after 24 h which was not significantly
different from the elevated expression observed 4 h after the meal
(Fig. 2D–E). No significant postprandial changes in gene
expression were observed for omy-miRNA-126a (df=6; F=1.51;
p.0.05). Of the miRNAs, whose mammalian homologues are
primarily involved in lipid metabolism, the expression of omy-
miRNA-33 (df=6; F=3.41; p,0.05) revealed an increased
expression 4 h after the meal when compared to the time of the
meal (Fig. 2H). Hepatic expression of the highly expressed omy-
miRNA-122b (df=6; F=3.05; p,0.05), but not of omy-miRNA-122a
(df=6; F=0.41; p.0.05), exhibited significant postprandial
changes. A significantly higher expression of omy-miRNA-122b
compared to the time of feeding was observed 4 h after refeeding
(Fig. 2I).
Post-prandial Phosphorylation Status of Key Components
of the Hepatic Insulin Signaling Pathway
The postprandial phosphorylation status changed for several
components of the insulin signaling pathway in the liver (Fig. 3A-
E). For the ratio of Akt-p/Akt (df=6; F=5.05; p,0.01), a
significant elevation in the ratio occurred at 2 h and the ratio
returns to basal levels after 8 h (Fig. 3A). The phosphorylation
ratio for the Akt target mTOR (df=6; F=4.18; p,0.01) increased
significantly 2 h and 8 h after refeeding (Fig. 3B). The mTOR
targets S6 (through activation of S6K) and 4-EBP1 equally
exhibited postprandial changes in phosphorylation status: for the
ratio of S6-p/S6 (df=6; F=11.60; p,0.01), a significant
postprandial increase was observed between 2 h-12 h, with a
maximum 4 h after refeeding (Fig. 3C). A significantly elevated
ratio of 4EBP1-p/4EBP1 (df=6; F=3.6; p,0.01) was equally
observed between 2 h and 16 h after refeeding (Fig. 3D). The
phosphorylation status of FoxO1 (df=6; F=3.27; p,0.05)
increased significantly 2 h after refeeding compared to the status
in fasted animals. (Fig. 3E).
Postprandial Regulation of Genes Involved Intermediary
Hepatic Metabolism
Hepatic expression of genes coding for the gluconeogenic
enzymes (Fig. 4), including m-pepck (df=6; F=3.96; p,0.01),
g6pase1 (df=6; F=16.5; p,0.01) and g6pase2 (df=6; F=5.02;
p,0.01) revealed significant postprandial decreases in expression
after refeeding, while fbpase did not (df=6; F=1.68; p=0.15). The
expression of m-pepck was significantly decreased 4 h, 12 h and
24 h after refeeding compared to its expression level at feeding
time (Fig. 4). The expression of g6pase1 was significantly decreased
between 8 h-24 h compared to the expression measured up to 4 h
after refeeding (Fig. 4). The expression of g6pase2 was significantly
decreased 4 h and 24 h after refeeding compared to its expression
at feeding time (Fig. 4).
The expression of genes involved in hepatic lipid metabolism
increased postprandially for lipogenic genes (Fig. 5A,B), including
srebp1c (df=6; F=7.13; p,0.01), fas (df=6; F=4.41; p,0.01),
and acly (df=6; F=3.74; p,0.01), but not g6pdh (df=6; F=1.13;
p=0.37). Post-hoc analysis reveals significant increases in the
expression of srebp1c between 2–4 h after refeeding compared to
expression at feeding time, with a second, smaller increase in
expression after 16 h that is not significantly different from the
expression observed between 2 h and 4 h (Fig. 5A). Expression of
fas increases significantly after 4 h and exhibits a second peak in
expression between 16–24 h that is not significantly different from
the expression observed 4 h after refeeding (Fig. 5B). The
postprandial expression of acly is significantly increased 24 h after
refeeding; however, this increase is preceded by a smaller, first
peak in expression between 2–4 h that is not significantly different
from the expression observed 24 h after refeeding. The expression
of the lipolytic genes (Fig. 5C), cpt1a (df=6; F=5.30; p,0.01) and
cpt1b (df=6; F=4.11; p,0.01), exhibited postprandial decreases
in expression. Both isoforms, cpt1a, and cpt1b, were significantly
decreased 4 h and 16 h after refeeding compared to the expression
level at the time of refeeding (Fig. 5C).
The hepatic expression of genes with a role in autophagy
changed postprandially (Fig. 6), as evidenced in the change in
gene expression of atg4b (df=6; F=3.85; p,0.01) and lc3b (df=6;
F=3.38; p,0.01). The expression of both genes significantly
decreased at 4 h and 24 h after refeeding (Fig. 6).
Discussion
The results obtained from our postprandial time course study of
rainbow trout refed after a short-term fast reveal acute postpran-
dial expression changes of microRNAs in the liver, which are
temporarily coordinated with changes in components of the
hepatic insulin signaling pathway and mRNA expression of
metabolic genes. To our knowledge, this study is the first study
to describe the postprandial regulation of hepatic expression of
miRNA in any species. The following discussion aims to explore
the potential for a role of miRNAs as a new layer of control in the
postprandial regulation of the hepatic insulin pathway in rainbow
trout.
Potential Roles for Hepatic Omy-miRNAs in the Negative
Feedback of Hepatic Insulin Signaling
Postprandial hepatic metabolism is regulated by insulin in both
mammals and fish [33]. The increased phosphorylation of Akt
points to insulin activation of its liver signaling pathways between
2–4 h after feeding. The postprandial activation of the hepatic
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insulin concentrations in trout fed the same diet as in the current
experiment [41]. The increased phosphorylation of Akt measured
in the current study returns to basal levels between 4–8 h therefore
implicates the presence of negative feedback mechanism(s) to
terminate the initial signaling at the Akt node. Based on
mammalian miRNAs known to inhibit the phosphorylation of
hepatic Akt (summarized in Fig. 1), we investigated the
postprandial expression of the homologous omy-miRNAs. Indeed,
an increase in postprandial expression of omy-miRNA-22, omy-
miRNA-29a, omy-miRNA-33, omy-miRNA-103, omy-miRNA-107 and
omy-miRNA-143 was found 4 h after refeeding, preceding the
observed attenuation of Akt phosphorylation status between 4–8 h
after the meal. This temporal pattern is in line with the predicted
inhibitory effects of these miRNAs on different components of the
insulin pathway upstream of Akt, such as IRS and PI3K in both
fish and mammals (Table 1). These results suggest also that omy-
miRNAs may acutely inhibit Akt phosphorylation, similarly to
their mammalian counterparts. For example, transient overex-
pression of hsa-miRNA-29, mmu-miRNA-143, mmu-miRNA-103 and
mmu-miRNA-107, inhibited insulin stimulated Akt phosphorylation
in mammalian models in vitro and in vivo [20,21,22]. We equally
investigated the expression of omy-miRNA-21a and omy-miRNA-22
based on the fact that their mammalian homologues have a
stimulating effect on hepatic Akt phosphorylation via repression of
PTEN [23,24]. Unexpectedly, the expression of omy-miRNA-22
increased 4 h after the meal, which would result in a stimulation of
Akt phosphorylation. This result may indicate that postprandial
regulation of miRNAs represents an intricate balance between
stimulatory and inhibitory effects on the insulin pathway. An
alternative hypothesis is that in rainbow trout, omy-miRNA-22,
albeit conserved in its sequence compared to mammals, may not
directly act on the same gene target, whose sequence conservation
is equally important in determining adequate miRNA binding, a
fact that has so far been neglected in studies investigating miRNA
expression in fish species [63]. The latter hypothesis is supported
by the prediction that that miRNA-22 targets PI3K subunits in
some fish species (Table 1), which would result in an inhibition of
Akt signaling in line with the observed decrease in Akt activation
after 8 h. Nevertheless, the temporally precise increase in several
miRNAs functionally associated with the mammalian insulin
signaling pathway points to a potential role for these miRNAs in
the acute postprandial regulation of the activity of the insulin
pathway in rainbow trout.
Transient Postprandial Increases of Omy-miRNA-29a,
Omy-miRNA-103, Omy-miRNA-107 and Omy-miRNA 143
are Consistent with a Stimulatory Role on the
Gluconeogenic Pathway
While the increase in hepatic omy-miRNA preceeding the return
of Akt phosphorylation status to baseline values are largely in line
with the known negative regulation of the hepatic insulin pathway
by homologous mammalian miRNAs, the functional consequences
of this inhibition on hepatic carbohydrate metabolism appear to
differ between trout and mammalian models. Similar to mamma-
lian models [23,24], activation of the hepatic insulin signaling
pathway in trout is correlated with decreased gluconeogenic gene
expression for g6pase1, g6pase2, and m-pepck, but not fbpase2 in our
study, confirming previous results showing a rapid inhibition of the
transcription and activity of gluconeogenic genes by bovine insulin
in trout, again with the exception of FBPase activity [37].
Furthermore, insulin induced activation of Akt and concurrently
decreased gluconeogenic gene expression of g6pase1 and m-pepck
correlate with increased FoxO1 phosphorylation in trout primary
hepatocytes, arguing for an evolutionary conserved mechanism
[37].
Assuming a conservation of the action of the homologous
miRNAs in trout, the elevated post-prandial expression of omy-
miRNA 29a, omy-miRNA-103, omy-miRNA-107 and miRNA-143
should therefore precede not only an inhibition of hepatic insulin
signaling in the form of Akt and FoxO1 phosphorylation, but also
preceed a subsequent de-repression of hepatic gluconeogenic gene
expression. Indeed, the increase in omy-miRNA29a, omy-miRNA-
103/107 and omy-miRNA-143 expression 4 h after the meal
precedes not only a decrease in Akt and FoxO1 phosphorylation
8 h after the meal, but also a mild, yet significant, attenuation of
the initial inhibition of m-pepck and g6pase2 expression. This is
evidenced by the fact that the postprandial hepatic expression of
the gluconeogenic genes m-pepck and g6pase2 is significantly
decreased 4 h following the meal, but not at 8 h following the
meal when compared to expression levels in fasted fish (T0).
Nevertheless, both the increase in the specific miRNAs at 4 h and
the attenuation of the initial repression of gluconeogenic genes at
8 h are transient, as the expression of both m-pepck, g6pase2 are
again significantly inhibited 24 h after the meal, an observation
that may be linked to the fact that proteins, the main component
in this diet, are stronger activators of the insulin pathway in trout
than carbohydrates [33] and can thus cause a stronger repression
of gluconeogenic genes [37]. Interestingly, the second decrease in
gluconeogenic gene expression after 24 h was again accompanied
by a second, albeit smaller increase in omy-miRNA-103 and omy-
miR-107, whose expression 24 h after the meal is not significantly
different from the previously observed expression peaks 4 h after
the meal. This observation strengthens the hypothesis that omy-
miRNA-103 and omy-miRNA-107 may be involved in a physiolog-
ical feedback to limit the repression of gluconeogenic gene
expression. In this context it is interesting to note that the host-
gene of miRNA-103 and miRNA-107, pank, codes for a key
enzyme whose expression [43] and activity [44] are essential to
maintain gluconeogenesis in fasted rats. Therefore, miRNA-103
and miRNA-107 may have evolved to coordinatively support their
host genes’ gluconeogenic function by attenuating insulin repres-
sion of gluconeogenic gene expression. It will be worthwhile to
further test the hypothesized regulatory role of omy-miRNA-103
and omy-miRNA-107 by challenging trout with a hyperglycaemic
diet (.20% carbohydrates), as the glucose intolerant phenotype in
trout has been linked to a constitutively active gluconeogenic
pathway in the liver [45], similar to the situation of human type-II
diabetic patients [3]. As aberrant expression of the described
mammalian miRNA homologues is observed in type-II diabetes
and obesity models [5,6,7], this may elucidate not only the
metabolic phenotype of rainbow trout, but contribute to the
understanding of metabolic pathologies. Overall, the postprandial
omy-miRNA expression pattern is largely consistent with the
described role of their mammalian homologues and may acutely
interact with the insulin pathway in trout to regulate gluconeo-
genic gene expression.
Figure 2. Postprandial expression profiles of hepatic omy-miRNA involved predicted to be involved in glucose metabolism (A) and
lipid metabolism (B). Means and S.E. of n=6 samples per group, are shown. Data were analysed using a one-way ANOVA, followed by the
Newman-Keuls post-hoc test. Different letters indicate a significant difference at p,0.05.
doi:10.1371/journal.pone.0038604.g002
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Correspond to the Acute Induction of Lipogenic
Pathways in the Liver
The second functional group of miRNAs investigated in trout
was chosen based on the role of their mammalian homologues on
the hepatic insulin pathway and lipid metabolism.
We specifically investigated the postprandial hepatic expression
of two miRNAs, omy-miRNA-33 and omy-miRNA-122b, whose
mammalian homologues act on the hepatic insulin pathway to
stimulate lipogenesis and inhibit lipolysis [46]. A miRNA-33
homologue has only recently been characterized in fish [47] and
appears to be similar to isoform hsa-miRNA-33a in humans. In
humans, two miRNA-33 isoforms exist in two separate srebp host
genes, where they augment the host gene’s regulation of lipid
metabolism [18]. Conversely, two isoforms of miRNA-122, omy-
miRNA-122a and omy-miRNA122b, exist in rainbow trout [33],
contrary to the situation in humans, where a single isoform exists.
However in both, rainbow trout and higher vertebrates, miRNA-
122 is highly abundant and liver specific [48].
To characterize the postprandial regulation of hepatic lipid
metabolism we measured the expression of lipogenic (srebp1c, fas,
acly) and lipolytic genes (cpt1a, cpt1b) and observed a synexpression
of lipogenic genes and concurrent inhibition of lipolytic genes 4 h
and 24 h after refeeding. The temporal synexpression of the
lipogenic genes confirms previous studies in several fish species
[34,49,50] and likely points to an evolutionary conserved role for
SREBP1 in transcribing key metabolic genes of lipogenesis [51].
However, the concomitantly observed inhibition of the lipolytic
genes at both postprandial time points strongly suggests an inverse
regulation of both pathways by upstream factors. Both, omy-
miRNA-33 and omy-miRNA-122b may represent such upstream
factors, as their mammalian homologues promote lipogenesis
while simultaneously inhibiting lipolysis by stimulating lipogenic
and inhibiting lipolytic gene expression in the liver. For example,
inhibition of mmu-miRNA-33 expression in vivo results in lowered
plasma VLDL triglyceride levels, and correlates with decreased
hepatic gene expression of srebp1, fas and acly, as well as increased
expression of cpt1a [19]. An inhibition of cpt1a expression and a
measurable decrease in fatty acid oxidation had also previously
been shown in human cell lines overexpressing hsa-miRNA-33a and
hsa-miRNA-33b [18]. Similarly inhibition of mmu-miRNA-122 in vivo
results in increased fatty acid oxidation and decreased fatty acid
synthesis rates and is further correlated with a decrease in srebp1,
fas and acly expression [25,29,52]. The lipogenic role of miRNA-
122 appears to be conserved in fish, based not only on
observations in our current study, but also by the detection of a
concurrent expression increase of dre-miRNA-122, srebp1c and fas in
a transgenic zebrafish model for hepatic steatosis [53]. In our
study, omy-miRNA-33 and omy-miRNA-122b increased 4 h after the
meal, consistent with the concomitant stimulation of lipogenic
genes and inhibition of lipolytic genes. Furthermore, the observed
postprandial expression pattern of omy-mRNA-122b decreases
sharply between 4 h to 12 h after feeding, a decrease which is
paralleled by a decrease in srebp, fas and to some extent acly, and a
transitory increase in cpt1a and cpt1b, providing further evidence
for a synexpression group. The lowest abundance of omy-mRNA-
122b occurs at the time of significantly increased plasma
concentration of triglycerides (data not shown), an endproduct of
the lipogenic pathway. This correlation points to the possibility of
an acute nutritional feedback regulation of the triglycerides on
omy-miRNA-122b, similar to the observation in studies of a
mammalian obesity model characterized by increased triglyceride
concentrations, which exhibited decreased miRNA-122 expression
[5]. Interestingly, hsa-miRNA-370 has recently been found to
equally coordinate lipogenic and lipolytic gene expression in in vitro
Figure 3. Temporal profile of components of the insulin signaling pathway in rainbow trout, as determined by Western Blot
densitometry. Means and S.E. of n=6 samples per group are shown. Data were analysed using a one-way ANOVA, followed by the Newman-Keuls
post-hoc test. Different letters indicate a significant difference at p,0.05.
doi:10.1371/journal.pone.0038604.g003
Figure 4. Postprandial regulation of gene expression of hepatic enzymes involved in gluconeogenesis. Means and S.E. of n=6 samples
per group, are shown. Data were analyzed using a one-way ANOVA, followed by the Newman-Keuls post-hoc test. Different letters indicate a
significant difference at p,0.05.
doi:10.1371/journal.pone.0038604.g004
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expression on the one hand, and by inhibiting cpt1a expression
on the other [54]. However, no fish isoform of miRNA-370 has
been characterized to date, but it is tempting to speculate on a
similar role in the postprandial regulation of lipogenic genes, at
least in higher organisms.
The observed changes in miRNA gene expression are largely
consistent with the observed postprandial induction of the
lipogenic pathway and may therefore act to augment the lipogenic
role of insulin in trout liver [39], which is equally attributed to
increased expression of the lipogenic genes srebp1c, fas, acly and a
concurrent inhibition in the expression of the lipolytic gene cpt1a
[37].
Potential Involvement of MiRNA in Hepatic Autophagy
Gene Regulation
Interestingly, the insulin pathway has equally been shown to
inhibit hepatic autophagy gene expression in mammals, acting via
phosphorylation of mTOR [55] and FoxO1 [2]. In the context of
postprandial regulation of hepatic genes it is important to notice
that a pathway that has not only been implicated in regulating the
availability of intracellular metabolites [56], but also the regulation
of systemic macronutrient concentrations, including carbohydrates
and amino acids [15], as well as lipids [16]. In our study, we
observed an acute postprandial down-regulation of hepatic
expression of atg4b and lc3b, two genes involved in the complex
II formation of the autophagosomes [56], 4 h after the ingestion of
the meal. This effect correlated with increased activity of the
insulin pathway, as evidenced by a concomitant increase in Akt,
FoxO1 and mTOR phosphorylation status. Indeed, the observed
down-regulation of hepatic autophagy genes is consistent with a
conserved inhibitory effect of insulin on the regulation of hepatic
autophagy in mammals [2], but is contrary to the lack of effect of
insulin on the regulation of these genes in trout muscle [57].
Similarly to the transient effect observed in the repression of
gluconeogenic genes described earlier, the repression of atg4b and
lc3b is rapidly attenuated after 8 h. This attenuation is preceded by
an increase in the expression of several omy-miRNAs (omy-miRNA-
29a, omy-miRNA-103, omy-miRNA-107, omy-miRNA-143) 4 h after
the ingestion of the meal. All of these aforementioned miRNAs are
predicted to inhibit elements of the insulin pathway upstream of
Akt. Indeed, the expression increase in omy-miRNAs 4 h after the
meal is followed by a potent inhibition of Akt phosphorylation
status 8 h after the meal. Therefore, while our study largely failed
to identify omy-miRNAs that may directly inhibit autophagy
related genes, a miRNA-dependent regulation of the insulin
signaling pathway by specific miRNAs may indirectly contribute
to the attenuation of postprandial repression of hepatic autophagy
genes in the rainbow trout. A possible direct regulation may
however occur through omy-miRNA-29a, whose homologues in
stickleback and the green-spotted-puffer fish (Table 1) are
predicted to target the atg4b gene. Overall, this is consistent with
the prediction of the insulin pathway, as well as of specific
miRNAs different from those investigated in our study, as direct
regulators of autophagy [58]. With regard to the potential
postprandial regulation of the process of autophagy, it is important
to note, however, that changes in hepatic atg4 and lc3b gene
expression do not functionally prove autophagy in sensu strictu, and
future studies describing the postprandial functional activity of
hepatic autophagy in trout are warranted.
Conclusion and Future Directions
To our knowledge, this study is the first to investigate acute
postprandial regulation of hepatic miRNAs in vivo in any species.
The observed expression pattern of omy-miRNA-29a, omy-miRNA-
103/107 and omy-mRNA-143, as well as omy-miRNA-33 and omy-
Figure 5. Postprandial expression of genes involved in
lipogenesis (A,B) and lipolysis (C) Means and S.E. of n=6
samples per group, are shown. Data were analysed using a one-way
ANOVA, followed by the Newman-Keuls post-hoc test. Different letters
indicate a significant difference at p,0.05.
doi:10.1371/journal.pone.0038604.g005
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acutely activated insulin pathway. It is interesting to note that the
miRNAs chosen for their modulatory role in the mammal insulin
pathway were largely stimulated 4 h after refeeding, implicating a
potential regulation by the insulin pathway itself. It is however not
clear at this point, whether the increase in miRNA abundance is
caused by hormonal factors, distinct nutrients or a combination of
both. A regulation of miRNAs has been shown for both, insulin
[59], but also for nutritional factors, such as amino acids [60], in
muscle. While our current postprandial in vivo study cannot
adequately resolve this point, in vitro studies on trout hepatocytes
are warranted, to investigate the role/potential interaction of both
factors on miRNA regulation.
Additionally, miRNA antagonism studies similar to studies in
mammalian systems are required in trout and in fish species in
general, in order to validate the predicted miRNA target depicted
in Table 1. This is especially important with respect to investigate
predicted differences in miRNA targets between (human-fish) or
within vertebrate classes (fish), both of which are evident in
Table 1. While miRNAs are evolutionarily highly conserved
across animal phyla [61], the recognized sequence in potential
target genes may not be, a point which has not been addressed in
studies investigating miRNA expression in fish [63]. The
estimation of evolutionary conservation of miRNA function
between fish and mammals is further complicated by the fact that
in some fish species, such as rainbow trout, multiple miRNA
isoforms may exist, as exemplified by omy-miRNA-122a and b,
which are differentially regulated in our study [33].
The rainbow trout lends itself as a model to investigate miRNA
regulation of hepatic metabolism, especially due to its glucose-
resistant phenotype, characterized by a type-II diabetes pheno-
type, similar to mammals. With the recent identification of key
roles of miRNA for this phenotype in mammalian models [21,22],
and the current time course-study, comparative studies of miRNA
function in trout are warranted. The study of miRNA in hepatic
metabolism has additional importance for trout aquaculture as it
will undoubtedly contribute to a better understanding of the
nutritional regulation of intermediary metabolism in this tissue.
The fact that efforts to characterize miRNAs of rainbow trout
[33], as well as other commercially important fish species, such as
Barramundi, Latis calcifer [62], silver carp, Hypophthalmichthys molitrix
[47], the Japanese flounder, Paralychtis olivacaeus [63], and the
Atlantic halibut, Hippoglossus hippoglossus, [64] have recently been
made underlines the importance of this emerging research area.
Our study represents the first characterization of miRNAs in the
context of hepatic metabolism in fish, and will therefore provide a
framework for future investigations in aquaculture fish species.
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